HGSOC	High-Grade Serous Ovarian Cancer
HRD	Homologous Recombination Deficiency
TMB	Tumor Mutational Burden
TROP2	Trophoblast Cell-Surface Antigen 2
CA125	Cancer Antigen 125
GCIG	Gynecologic Cancer InterGroup
PFS	Progression-Free Survival
OS	Overall Survival
CT	Computed Tomography
ctDNA	Circulating Tumor DNA
VAF	Variant Allele Frequency
FGFR2	Fibroblast Growth Factor Receptor 2
BRCA	Breast Cancer Susceptibility Gene
HER2	Human Epidermal Growth Factor Receptor 2
FOLR1	Folate Receptor Alpha
PARP	Poly (ADP-Ribose) Polymerase
ADC	Antibody–Drug Conjugate
ORR	Objective Response Rate
DOR	Duration of Response
DAR	Drug–Antibody Ratio
GP1	Glycosyl-Phosphatidylinositol
LGOC	Low-Grade Serous Ovarian Cancer
NCCN	National Comprehensive Cancer Network